Vikas Sethi
Largo, FLNPI 1326675513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,797, 5.4 times the $333 reported in 2021.
Across 74 payments — averaging $73.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$906
- Madrigal Pharmaceuticals$682
- Takeda Pharmaceuticals U.S.A., Inc.$428
- Regeneron Healthcare Solutions, Inc.$389
- Gilead$384
- Sanofi$330
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,444100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $906 |
| Madrigal Pharmaceuticals | 5 | $682 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $428 |
| Regeneron Healthcare Solutions, Inc. | 5 | $389 |
| Gilead | 3 | $384 |
| Sanofi | 3 | $330 |
| Intercept Pharmaceuticals, Inc. | 4 | $250 |
| Amgen(2 entities) | 2 | $246 |
| Lilly USA, LLC | 4 | $190 |
| Ardelyx, Inc. | 3 | $174 |
| Johnson & Johnson | 2 | $152 |
| E.r. Squibb & Sons, L.L.C. | 1 | $147 |
| Aimmune Therapeutics, Inc. | 2 | $142 |
| Boston Scientific | 2 | $138 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Celltrion USA Inc. | 1 | $125 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Ferring Pharmaceuticals Inc. | 1 | $122 |
| Nestle Healthcare Nutrition Inc. | 1 | $113 |
| AstraZeneca | 1 | $103 |
| Bayer | 5 | $100 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Pfizer | 1 | $20 |
| Vivus LLC | 1 | $18 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.